University of Nottingham School of Medicine
The biggest modern breakthrough for cancer treatment has been antibody therapies. An increasing number of biotechnology companies have antibody – or vaccine-based cancer therapies in development. This course aims to attract students interested in tumour immunology who wish to pursue a career either in industry (biotechnology) or academia.
- Acquire a specialised knowledge in tumour immunology with particular reference to monoclonal antibody and cancer vaccines
- Develop the critical and analytical power to evaluate scientific literature
- Perform a scientific research project
- Acquire the ability to communicate scientific results orally and in writing
- Learn about business exploitation of cancer therapy
Entry requirements
Please contact the course provider.
Closing date
Please contact the course provider.